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Letter to the Editor
Glycaemic index: did Health Canada get it wrong? Position from the
International Carbohydrate Quality Consortium (ICQC)
On behalf of Health Canada, Aziz et al.(1) recently published
their evaluation of the use of glycaemic index (GI) claims on
food labels. Although the importance of controlling post-
prandial glycaemia (PPG) was recognised in the position
statement, they expressed the view that the GI could be
‘misleading’ and ‘would not add value’ to the existing standards
for nutrition labels. Unfortunately, several statements indicate
a lack of understanding of the evidence base for current
information on food labels and of the GI concept in particular.
The clinical relevance of PPG is now recognised by health
institutions worldwide(2,3). Ideally, plasma glucose levels at
the 2 h time point after a meal should be ,7·8 mmol/l since
values above this level are considered to indicate the presence
of impaired glucose tolerance (IGT), which may be indicative
of pre-diabetes, a condition which is more prevalent than
diabetes itself. Both type 2 diabetes mellitus and IGT are
increasing at an alarming rate, largely due to obesity and
sedentary lifestyles. Mitigating the risk of adverse outcomes
associated with elevated PPG is an important target for
population health.
For food labelling purposes, the challenge is to find the
best tool for evaluating a product’s impact on PPG within
the context of other health recommendations. Although the
GI has a long history of use in research and clinical practice,
Aziz et al.(1) concluded that the GI was not useful because:
(1) it has poor accuracy and precision for labelling purposes,
(2) it does not vary in response to the amount of food
consumed and (3) it is not congruent with national nutritional
policies and guidelines.
To address the first issue, the GI methodology is recognised
and described by the International Standards Organization
(26 642:2010) and by the Food and Agriculture Organization
of the United Nations(4) as a method to assess the glycaemic
impact of available carbohydrates. The GI value of one food
is calculated from 640 data points (ten subjects, eight blood
samples, in duplicate, one test series for the test food and
three test series for the reference food). The margin of error
of ,15 % (i.e. the standard error of the mean expressed
as a percentage of the mean) is considered reliable in the
context of the considerable day-to-day variation in glucose
tolerance in healthy individuals ( ^ 30–50 %)(5). By testing a
reference food, the GI method takes into account ‘between-
person variation’.
Concerning the accuracy and precision of any nutritional
attribute, one cannot let perfect be the enemy of good. For
example, both whole-grain and fibre claims are permitted
on food labels, despite the fact that the definition and
measurement of each varies among nations and is neither
perfect nor precise. A whole-grain product may contain only
50 % whole grains according to the Food and Drug Adminis-
tration, and there is marked disagreement of what fibre is
and how it should be measured. Moreover, total carbohydrates
on food labels are often described as ‘carbohydrate by
difference’, which is calculated by subtracting the sum of the
water, protein, fat, dietary fibre, ash and alcohol contents
from 100. This method compounds the errors associated
with all assays and often differs markedly from the direct
measurement of the available carbohydrate. In addition,
there is a permitted margin of error of ,20 % for any com-
ponent listed in the nutrition panel, which is considerably
higher than the margin of error considered reliable for the
GI of a food (,15 %). In this context, the GI is being held
to a much higher standard than other nutritional attributes.
The second issue identified by Aziz et al.(1) was that the GI
does not vary in response to the amount of food consumed.
Informed consumers would anticipate that the greater the
amount of the available carbohydrate consumed, the greater
the increase in blood glucose. The key value of the
GI therefore is that it allows comparisons between foods on
a gram-for-gram carbohydrate basis, which is important for
consumer choice. The glycaemic load (GL) per serving (the
product of the available carbohydrate content £ GI) varies in
response to the amount consumed(6), and could be included
in the nutrient panel together with the GI.
With respect to the third issue, Health Canada claims that
the GI is not congruent with national nutritional policies and
guidelines, implying that the GI would be used in isolation,
irrespective of other important attributes such as saturated
fat, fibre and whole grain content. We agree that the GI
should not override sound dietary advice(1). However, this
concern relates to any dietary claim, including ‘low fat’ and
‘high fibre’. Of note, Health Canada’s concern is inconsistent
with their earlier statement that ‘low-GI diets have attributes
of generally recognized healthy eating patterns’(1). However,
to address their concern that the composition of a low-GI
food may not always be congruent with nutritional guidelines,
our suggestion would be to consider a GI claim in conjunction
with a healthy food profile. Programmes such as the GI
symbol in Australia require the fulfilment of strict nutritional
criteria that are consistent with dietary guidelines in order
for a food to be eligible to use the certified GI logo.
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We agree with Aziz et al.(1) that ‘consumers are familiar
with the concept, even though their understanding of it might
not be accurate’. In our view, this largely reflects the lack
of communication about the GI to the general public and
health professionals. The assumption that the GI concept
may be too difficult for the lay person is not supported by
the Australian experience, where surveys indicate that one in
four Australians look for healthy low-GI foods when shopping,
simply substituting healthy low-GI varieties for regular high-GI
variants within a food group/category(7). Moreover, low-GI
dietary advice in randomised clinical trials is associated with
high completion rates (low attrition), suggesting that simple
low-GI communications can be effective(8,9). As in the case
of quality of fat (saturated, monounsaturated and poly-
unsaturated), health agency advice preceded information now
commonly listed in the nutritional panel(10).
Finally, in their conclusions, Aziz et al.(1) proposed that
nutritional recommendations should take a food-based
approach. We agree, yet Health Canada’s recommendation to
increase intakes of whole foods in the form of vegetables,
fruits, grains and pulses does not address the main carbohydrate
sources of most populations, i.e. breads, breakfast cereals, rice
and ready-to-eat cereal products. Pasta, a staple carbohydrate
food of the heart-healthy Mediterranean diet, is a refined yet
low-GI carbohydrate food. Most basmati and parboiled rice
are white yet have a low GI. There is also a need to distinguish
high-GI from low-GI whole grains. Indeed, advice to ‘choose
more intact, unprocessed or minimally processed whole-grain
products instead of their highly processed counterparts’ is
aimed at lowering overall dietary GI or GL. It is a common
myth that all whole-grain products have low-GI values when
in fact many are highly processed and correspondingly easy
to digest(11). In clinical trials, low-GI diets have produced
superior outcomes compared with the high-fibre–high-GI
diets(8,9,12). We suggest that GI labels may in fact stimulate the
food industry to produce genuinely healthier whole-grain
products that retain the low GI of the original grain.
Finally, if GI values are misleading and unreliable as Health
Canada claims, then it is truly remarkable that a lower dietary
GI/GL has been independently associated with a reduced risk
of type 2 diabetes(13) and cardiovascular disease(14) in large
prospective cohort studies of diverse populations(15). Similarly,
randomised controlled trials have shown the benefits of
low-GI diets for weight management(8,9,12), serum lipids(9,12,16),
insulin sensitivity(17) and inflammatory markers(18). Most
importantly, the selection of low-GI foods has resulted in the
successful improvements of glycaemic control, dyslipidaemia
and inflammation in people with type 2 diabetes(9,18,19). In
this regard, these lines of evidence have been used to support
the inclusion of low-GI and low-GL dietary patterns in the
evidence-based nutrition recommendations of the Canadian
Diabetes Association, American Diabetes Association, Diabetes
UK, Diabetes Australia, International Diabetes Federation and
the European Association for the Study of Diabetes(20). If GI
values were not precise, one would not expect to see distinct
differences in PPG in response to low- or high-GI meals
observed at different time points throughout the day(12).
These beneficial outcomes would not be possible if the GI
concept were unduly undermined by large variability or differ-
ences among people of different ethnicity.
Taken together, Health Canada’s evaluation misinterprets
and misrepresents current scientific evidence, in part by
taking the GI outside the context of a healthy diet. In view
of the proven health benefits of low-GI diets ‘as currently
defined and measured’, every effort should be made to assist
consumers in choosing carbohydrate foods that will not
exacerbate PPG.
Authors
International Carbohydrate Quality Consortium (ICQC)
David J. A. Jenkins (ICQC chair), Department of Nutritional
Sciences, Faculty of Medicine, University of Toronto, Clinical
Nutrition and Risk Factor Modification Centre, St Michael’s
Hospital, Toronto, Ontario, Canada.
Walter C. Willett (ICQC chair), Department of Nutrition,
Harvard School of Public Health, Boston, MA, USA.
Arne Astrup, Department of Nutrition, Exercise and Sports
(NEXS), Faculty of Science, University of Copenhagen, Copen-
hagen, Denmark.
Livia S. A. Augustin*, Clinical Nutrition and Risk Factor Modi-
fication Centre, St Michael’s Hospital, Toronto, Ontario,
Canada.
Sara Baer-Sinnott, Oldways, Boston, MA, USA.
Alan W. Barclay, Australian Diabetes Council, Glycemic Index
Foundation, Sydney, Australia.
Inger Bjo¨rck, Antidiabetic Food Centre, Lund University, Lund,
Sweden.
Jennie C. Brand-Miller, Boden Institute of Obesity, Nutrition,
Exercise and Eating Disorders, University of Sydney, Sydney,
Australia.
Furio Brighenti, Department of Food Science, University of
Parma, Parma, Italy.
Anette E. Buyken, Department of Nutritional Epidemiology,
University of Bonn, Bonn, Germany.
Antonio Ceriello, Institut d’Investigacions Biome`diques August
Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Cyril W. C. Kendall, Department of Nutritional Sciences,
Faculty of Medicine, University of Toronto, Toronto, Ontario,
Canada; College of Pharmacy and Nutrition, University of
Saskatchewan, Saskatoon, Canada.
Carlo La Vecchia, Department of Epidemiology, Mario Negri
Institute, and Professor of Epidemiology, University of Milan,
Milan, Italy.
Geoffrey Livesey, Independent Nutrition Logic, Wymondham,
UK.
Simin Liu, Department of Epidemiology and Medicine, Brown
University, Providence, RI, USA.

















Andrea Poli, Nutrition Foundation of Italy, Milan, Italy.
Gabriele Riccardi, Department of Clinical Medicine and Sur-
gery, Federico II University, Naples, Italy.
Salwa W. Rizkalla, National Institute of Health and Medical
Research (INSERM), ICAN Institute of Cardiometabolism &
Nutrition, University Pierre et Marie Curie – Paris 6, Centre
of Research in Human Nutrition, Pitie´ Salpeˆtrie`re Hospital,
Paris, France.
John L. Sievenpiper, Toronto 3D Knowledge Synthesis and
Clinical Trials Unit, Clinical Nutrition and Risk Factor Modifi-
cation Centre, St Michael’s Hospital, Toronto, Ontario,
Canada; Department of Pathology and Molecular Medicine,
Faculty of Health Sciences, McMaster University, Hamilton,
Ontario, Canada.
Antonia Trichopoulou, World Health Organization Collaborat-
ing Centre for Food & Nutrition, Department of Hygiene and
Epidemiology, University of Athens Medical School, Hellenic
Health Foundation, Athens, Greece.
Thomas M. S. Wolever, Department of Nutritional Sciences,
University of Toronto, Toronto, Ontario, Canada.
*Corresponding author
Clinical Nutrition and
Risk Factor Modification Centre
St Michael’s Hospital








1. Aziz A, Dumais L & Barber J (2013) Health Canada’s evalu-
ation of the use of glycemic index claims on food labels.
Am J Clin Nutr 98, 269–274.
2. International Diabetes Federation (IDF) (2013) IDF Diabetes
Atlas – Fifth edition: Impaired Glucose Tolerance Estimates
– IGT Prevalence 2011. http://www.idf.org/diabetesatlas/5e/
the-global-burden (accessed August 2013)
3. European Food Safety Authority (EFSA) Panel on Dietetic Pro-
ducts, Nutrition and Allergies (NDA) (2011) Scientific opinion
on the substantiation of a health claim related to “slowly
digestible starch in starch-containing foods” and “reduction
of post-prandial glycaemic responses” pursuant to Article
13(5) of Regulation (EC) No. 1924/20061. EFSA J 9, 2292.
4. Food and Agriculture Organization of the United Nations
(1998) Carbohydrates in Human Nutrition. Rome: Food
and Agriculture Organization of the United Nations (Food
and Nutrition Paper 66).
5. Wolever TM, Brand-Miller JC, Abernethy J, et al. (2008)
Measuring the glycemic index of foods: interlaboratory
study. Am J Clin Nutr 87, 247S–257S.
6. Bao J, Atkinson F, Petocz P, et al. (2011) Prediction of post-
prandial glycemia and insulinemia in lean, young, healthy
adults: glycemic load compared with carbohydrate content
alone. Am J Clin Nutr 93, 984–996.
7. Mitchell HL (2008) The glycemic index concept in action.
Am J Clin Nutr 87, 244S–246S.
8. Larsen TM, Dalskov SM, van Baak M, et al. (2010) Diets with
high or low protein content and glycemic index for weight-
loss maintenance. N Engl J Med 363, 2102–2113.
9. Jenkins DJ, Kendall CW, Augustin LS, et al. (2012) Effect of
legumes as part of a low glycemic index diet on glycemic
control and cardiovascular risk factors in type 2 diabetes
mellitus: a randomized controlled trial. Arch Intern Med
172, 1653–1660.
10. Atkinson FS, Foster-Powell K & Brand-Miller JC (2008) Inter-
national tables of glycemic index and glycemic load values:
2008. Diabetes Care 31, 2281–2283.
11. Krauss RM, Eckel RH, Howard B, et al. (2000) AHA Dietary
Guidelines: revision 2000: A statement for healthcare
professionals from the Nutrition Committee of the American
Heart Association. Circulation 31, 2284–2299.
12. McMillan-Price J, Petocz P, Atkinson F, et al. (2006) Compari-
son of 4 diets of varying glycemic load on weight loss and
cardiovascular risk reduction in overweight and obese
young adults: a randomized controlled trial. Arch Intern
Med 166, 1466–1475.
13. Livesey G, Taylor R, Livesey H, et al. (2013) Is there a dose–
response relation of dietary glycemic load to risk of type 2
diabetes? Meta-analysis of prospective cohort studies. Am J
Clin Nutr 97, 584–596.
14. Liu S, Willett WC, Stampfer MJ, et al. (2000) A prospective
study of dietary glycemic load, carbohydrate intake, and risk
of coronary heart disease in US women. Am J Clin Nutr 71,
1455–1461.
15. Mirrahimi A, de Souza RJ, Chiavaroli L, et al. (2012) Associ-
ations of glycemic index, load and their dose with CHD
events: a systematic review and meta-analysis of prospective
cohorts. J Am Heart Assoc 1, e000752.
16. Goff LM, Cowland DE, Hooper L, et al. (2013) Low
glycaemic index diets and blood lipids: a systematic review
and meta-analysis of randomised controlled trials. Nutr
Metab Cardiovasc Dis 23, 1–10.
17. Rizkalla SW, Taghrid L, Laromiguiere M, et al. (2004)
Improved plasma glucose control, whole-body glucose util-
ization, and lipid profile on a low-glycemic index diet in
type 2 diabetic men: a randomized controlled trial. Diabetes
Care 27, 1866–1872.
18. Wolever TM, Gibbs AL, Mehling C, et al. (2008) The
Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y
controlled trial of low-glycemic-index dietary carbohydrate
in type 2 diabetes: no effect on glycated hemoglobin but
reduction in C-reactive protein. Am J Clin Nutr 87, 114–125.
19. Brand-Miller J, Hayne S, Petocz P, et al. (2003) Low-glycemic
index diets in the management of diabetes: a meta-analysis
of randomized controlled trials. Diabetes Care 26, 2261–2267.
20. Canadian Diabetes Association Clinical Practice Guidelines
Expert Committee (2013) Clinical Practice Guidelines for
the Prevention and Management of Diabetes in Canada.
Can J Diabetes 37, Suppl. 1, S1–S212.
Letter to the Editor382
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
